TWA
RCKT icon

TCI Wealth Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

TCI Wealth Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-332
Closed -$5.69K – 1758
2023
Q1 		$5.69K Hold
332
– – ﹤0.01% 1439
2022
Q4 		$6.5K Hold
332
– – ﹤0.01% 1358
2022
Q3 		$5K Hold
332
– – ﹤0.01% 1508
2022
Q2 		$5K Buy
+332
New +$3.96K ﹤0.01% 1525
2021
Q4 		– Sell
-122
Closed -$4K – 2479
2021
Q3 		$4K Sell
122
-125
-51% -$4.55K ﹤0.01% 1805
2021
Q2 		$11K Buy
247
+186
+305% +$8.08K ﹤0.01% 920
2021
Q1 		$3K Buy
+61
New +$3.35K ﹤0.01% 1573

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return